Developing immunotherapy strategies in the treatment of prostate cancer
The clinical development of immunotherapy has gained significant impetus in recent years across the field of medical oncology. Mounting preclinical and clinical data have demonstrated the potential of immune-based treatments to augment anti-tumor immune responses. With one of the first modern immuno...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2016-10-01
|
| Series: | Asian Journal of Urology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214388216300534 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849764054016458752 |
|---|---|
| author | James L. Gulley Ravi A. Madan |
| author_facet | James L. Gulley Ravi A. Madan |
| author_sort | James L. Gulley |
| collection | DOAJ |
| description | The clinical development of immunotherapy has gained significant impetus in recent years across the field of medical oncology. Mounting preclinical and clinical data have demonstrated the potential of immune-based treatments to augment anti-tumor immune responses. With one of the first modern immunotherapies approved in prostate cancer and multiple others in late stage development, immune treatment strategies need to be optimized to ensure the best clinical outcomes. Combination strategies with androgen deprivation therapy, anti-androgen therapy, radiation and chemotherapy have demonstrated the potential maximize immune response in prostate cancer patients. These combinations are currently being evaluated in clinical trials at every stage of prostate cancer from the newly diagnosed to the most advanced stages. Data from these studies will provide guidance for the future clinical implementation of immunotherapy in prostate cancer. Keywords: Prostate cancer, Immunotherapy, Combination therapies |
| format | Article |
| id | doaj-art-c12ea160ce784bab885eca130cff0fbf |
| institution | DOAJ |
| issn | 2214-3882 |
| language | English |
| publishDate | 2016-10-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Asian Journal of Urology |
| spelling | doaj-art-c12ea160ce784bab885eca130cff0fbf2025-08-20T03:05:14ZengElsevierAsian Journal of Urology2214-38822016-10-013427828510.1016/j.ajur.2016.08.008Developing immunotherapy strategies in the treatment of prostate cancerJames L. Gulley0Ravi A. Madan1Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USACorresponding author.; Genitourinary Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USAThe clinical development of immunotherapy has gained significant impetus in recent years across the field of medical oncology. Mounting preclinical and clinical data have demonstrated the potential of immune-based treatments to augment anti-tumor immune responses. With one of the first modern immunotherapies approved in prostate cancer and multiple others in late stage development, immune treatment strategies need to be optimized to ensure the best clinical outcomes. Combination strategies with androgen deprivation therapy, anti-androgen therapy, radiation and chemotherapy have demonstrated the potential maximize immune response in prostate cancer patients. These combinations are currently being evaluated in clinical trials at every stage of prostate cancer from the newly diagnosed to the most advanced stages. Data from these studies will provide guidance for the future clinical implementation of immunotherapy in prostate cancer. Keywords: Prostate cancer, Immunotherapy, Combination therapieshttp://www.sciencedirect.com/science/article/pii/S2214388216300534 |
| spellingShingle | James L. Gulley Ravi A. Madan Developing immunotherapy strategies in the treatment of prostate cancer Asian Journal of Urology |
| title | Developing immunotherapy strategies in the treatment of prostate cancer |
| title_full | Developing immunotherapy strategies in the treatment of prostate cancer |
| title_fullStr | Developing immunotherapy strategies in the treatment of prostate cancer |
| title_full_unstemmed | Developing immunotherapy strategies in the treatment of prostate cancer |
| title_short | Developing immunotherapy strategies in the treatment of prostate cancer |
| title_sort | developing immunotherapy strategies in the treatment of prostate cancer |
| url | http://www.sciencedirect.com/science/article/pii/S2214388216300534 |
| work_keys_str_mv | AT jameslgulley developingimmunotherapystrategiesinthetreatmentofprostatecancer AT raviamadan developingimmunotherapystrategiesinthetreatmentofprostatecancer |